|  Nederlands |  English |
 
 

08/10/2002: Scientists elect Johnson & Johnson as third most attractive employer in the world

Science Magazine publishes the survey results in its October issue.
Beerse, October 8, 2002 – Science Magazine, the leading journal for scientists, conducted a survey among its own readers asking which companies made the best employers and why.

The Top Three
Genentech, Millennium Pharmaceuticals and Johnson & Johnson make up the top tier. The first two are young companies specializing in biotechnology. Johnson & Johnson is placed third in the survey as first of the traditional pharmas. The company holds high grades for the attributes “social responsibility”, “a good financial investment” and “work and personal values are aligned”.

Confirmation of R&D Management
Within Johnson & Johnson, Janssen Pharmaceutica holds an important position. The research department in Beerse represents 36% of the global R&D employment, and an investment of 775 million Euros in 2001.

Further Awards Johnson & Johnson received in 2002
- In Belgium Janssen Pharmaceutica was awarded the Randstad prize as Most Attractive Employer earlier this year.
- Johnson & Johnson was ranked first on the Financial Performance list 2002 of Business Week.
- Johnson & Johnson was also ranked first this year in a reputation survey from Pharmaceutical Review, an international specialist journal.
- Third time in a row Johnson & Johnson was voted first of the RQ Gold of the Reputation Institute and the Wall Street Journal. The RQ Gold measures the “Reputation Quotient” of companies.
- March this year Johnson & Johnson was voted 7th in Fortune’s list of Most Admired Companies.
- Johnson & Johnson received an “AAA score” in 2002 in a survey carried out by Rating Research LLC (RRC).

Johnson & Johnson is a global organization, specializing in products for health and healthcare. In 2001 the company reached a turnover of 32.3 million dollar, the result of the activities of 194 operating companies in 54 countries.

Janssen Pharmaceutica is the Belgian subsidiary of Johnson & Johnson, with sites in Beerse, Geel and Olen. Janssen Pharmaceutica employs over 4000 people in Belgium and is active in research, chemical and pharmaceutical production for global marketing.

 
Press Releases 2002
04/12/2002 Laboratory Technician Day on December 4, 2002 for the Kempen Catholic Technical College of Geel: an opportunity to become acquainted with Janssen Pharmaceutica in Beerse and… perhaps even the key to your future!
11/12/2002 Janssen Pharmaceutica invests another 50 million euros
08/10/2002 Scientists elect Johnson & Johnson as third most attractive employer in the world
20/09/2002 Janssen Pharmaceutica Goes for Public Transportation
10/09/2002 Durogesic reaches a milestone
01/09/2002 Risperdal Consta, a new generation of atypical antipsychotics
04/07/2002 2001 - A very successful year for Janssen Pharmaceutica
03/07/2002 Prime Minister Guy Verhofstadt lays the first stone of the new Discovery Research Center in Beerse
22/05/2002 "Beerse 2" is biggest computer- and telecomcenter for J&J-group in Europe
05/05/2002 Open house at Janssen Pharmaceutica in Geel a success!
18/04/2002 Data suggest Reminyl effectively treats dementia in patients with cerebrovascular disease
15/04/2002 Investing in research: patients are Worth the Risk
12/04/2002 J&J in top 50 Business week
04/04/2002 Janssen Pharmaceutica NV most engaging employer in Belgium
 

 

 
© Janssen Pharmaceutica N.V., 1997-2008.

This site is published by Janssen Pharmaceutica NV and is intended for visitors from Europe. Use of the site constitutes your consent to application of European laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.